These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 10230181)

  • 41. Long-term safety of stimulant medications used to treat children with ADHD.
    Lerner M; Wigal T
    Pediatr Ann; 2008 Jan; 37(1):37-45. PubMed ID: 18240852
    [No Abstract]   [Full Text] [Related]  

  • 42. Stimulant drug effects on attention deficit/hyperactivity disorder: a review of the effects of age and sex of patients.
    Cornforth C; Sonuga-Barke E; Coghill D
    Curr Pharm Des; 2010; 16(22):2424-33. PubMed ID: 20513225
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of stimulants on Hispanic boys' height and weight.
    Farietta-Murray T; Castellanos D; Katsikas S
    J Am Acad Child Adolesc Psychiatry; 2007 Feb; 46(2):150-1. PubMed ID: 17242617
    [No Abstract]   [Full Text] [Related]  

  • 44. Stimulant medication for the child with attention-deficit/hyperactivity disorder.
    Bennett FC; Brown RT; Craver J; Anderson D
    Pediatr Clin North Am; 1999 Oct; 46(5):929-44, vii. PubMed ID: 10570697
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CNS stimulant controversies.
    Levy F
    Aust N Z J Psychiatry; 1989 Dec; 23(4):497-502. PubMed ID: 2575372
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Attention deficit hyperactivity disorder medications in children with heart disease.
    Berger S
    Curr Opin Pediatr; 2016 Oct; 28(5):607-12. PubMed ID: 27261563
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacotherapy of adult attention deficit hyperactivity disorder (ADHD): a meta-analysis.
    Mészáros A; Czobor P; Bálint S; Komlósi S; Simon V; Bitter I
    Int J Neuropsychopharmacol; 2009 Sep; 12(8):1137-47. PubMed ID: 19580697
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Attention deficit and hyperactivity disorder: controversies of diagnosis and safety of pharmacological and nonpharmacological treatment.
    Benner-Davis S; Heaton PC
    Curr Drug Saf; 2007 Jan; 2(1):33-42. PubMed ID: 18690948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Deciding on stimulant use for childhood ADHD: maintaining focus on the key questions.
    McLennan JD
    Can Fam Physician; 2006 Aug; 52(8):940-1, 945-6. PubMed ID: 17273490
    [No Abstract]   [Full Text] [Related]  

  • 50. Long-term safety of stimulant medications used to treat children with ADHD.
    Lerner M; Wigal T
    J Psychosoc Nurs Ment Health Serv; 2008 Aug; 46(8):38-48. PubMed ID: 18777967
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of the American Heart Association scientific statement on screening electrocardiograms and stimulant medications.
    Thomas PE; Carlo WF; Decker JA; Cannon BC; Kertesz NJ; Friedman RA; Kim JJ
    Arch Pediatr Adolesc Med; 2011 Feb; 165(2):166-70. PubMed ID: 21300657
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Stimulant side effects and inverted-U: implications for ADHD guidelines.
    Levy F
    Aust N Z J Psychiatry; 2013 Mar; 47(3):217-21. PubMed ID: 22689336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Management of stimulant medications in children with attention-deficit/hyperactivity disorder.
    Adesman AR; Morgan AM
    Pediatr Clin North Am; 1999 Oct; 46(5):945-63, vii-viii. PubMed ID: 10570698
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Side effects of stimulant use.
    Levy F
    J Paediatr Child Health; 1993 Aug; 29(4):250-4. PubMed ID: 8104015
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interventions in ADHD: A comparative review of stimulant medications and behavioral therapies.
    Rajeh A; Amanullah S; Shivakumar K; Cole J
    Asian J Psychiatr; 2017 Feb; 25():131-135. PubMed ID: 28262134
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dopamine receptors and the pharmacogenetics of side-effects of stimulant treatment for attention-deficit/hyperactivity disorder.
    Levy F; Wimalaweera S; Moul C; Brennan J; Dadds MR
    J Child Adolesc Psychopharmacol; 2013 Aug; 23(6):423-5. PubMed ID: 23952191
    [No Abstract]   [Full Text] [Related]  

  • 57. Children don't think that stimulant drugs for ADHD rob them of their "authenticity" and moral responsibility.
    Kmietowicz Z
    BMJ; 2012 Oct; 345():e6947. PubMed ID: 23071287
    [No Abstract]   [Full Text] [Related]  

  • 58. Effect of stimulants on final adult height.
    Wojnowski NM; Zhou E; Jee YH
    J Pediatr Endocrinol Metab; 2022 Nov; 35(11):1337-1344. PubMed ID: 36193720
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The use of stimulant medication to treat neurocognitive deficits in patients with pediatric cancer, traumatic brain injury, and sickle cell disease: a review.
    Nicholls E; Hildenbrand AK; Aggarwal R; McCarthy L; Daly B
    Postgrad Med; 2012 Sep; 124(5):78-90. PubMed ID: 23095428
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of ADHD with stimulant medications: response to Nissen perspective in the New England Journal of Medicine.
    Biederman J; Spencer TJ; Wilens TE; Prince JB; Faraone SV
    J Am Acad Child Adolesc Psychiatry; 2006 Oct; 45(10):1147-1150. PubMed ID: 16840880
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.